Who Should Pay for Global Health, and How Much?

article has not abstract

Vyšlo v časopise: Who Should Pay for Global Health, and How Much?. PLoS Med 10(2): e32767. doi:10.1371/journal.pmed.1001392
Kategorie: Policy Forum
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001392

Souhrn

article has not abstract

Zdroje

1. FidlerDP (1996) Globalization, international law, and emerging infectious diseases. Emerg Infect Dis 2: 77.

2. GouldEA, GallianP, De LamballerieX, CharrelRN (2010) First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality!. Clin Microbiol Infec 16: 1702–1704.

3. GasconJ, BernC, PinazoMJ (2010) Chagas disease in Spain, the United States and other non-endemic countries. Acta Tropica 115: 22–27.

4. Chen LC, Evans TG, Cash RA (1999) Health as a global public good. Kaul I, Grunberg I, Stern M, editors. Global public goods: international cooperation in the 21st century. New York: Oxford University Press.

5. Kassalow JS, Fund MM (2001) Why health is important to US foreign policy. New York: Council on Foreign Relations.

6. SachsJD, McArthurJW (2005) The millennium project: a plan for meeting the millennium development goals. Lancet 365: 347–353.

7. Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, et al.. (2006) Disease control priorities in developing countries. New York: Oxford University Press.

8. Tan-Torres EdejerT, AikinsM, BlackR, WolfsonL, HutubessyR, et al. (2005) Cost effectiveness analysis of strategies for child health in developing countries. BMJ 331: 1177.

9. MorelCM, LauerJA, EvansDB (2005) Cost effectiveness analysis of strategies to combat malaria in developing countries. BMJ 331: 1299.

10. GoodmanCA, ColemanPG, MillsAJ (1999) Cost-effectiveness of malaria control in sub-Saharan Africa. Lancet 354: 378–385.

11. High-Level Taskforce on International Innovative Financing for Health Systems (2009) Working Group 1 technical report: constraints to scaling up and costs. Available: http://www.who.int/pmnch/media/membernews/2009/20090313_hltfmeeting/en/index.html. Accessed 18 January 2013.

12. Leach-KemonK, ChouDP, SchneiderMT, TardifA, DielemanJL, et al. (2012) The global financial crisis has led to a slowdown in growth of funding to improve health in many developing countries. Health Affair 31: 228–235.

13. HardinG (1968) The tragedy of the commons. Science 162: 1243–1248.

14. OstromE, BurgerJ, FieldCB, NorgaardRB, PolicanskyD (1999) Revisiting the commons: local lessons, global challenges. Science 284: 278–282.

15. DietzT, OstromE, SternPC (2003) The struggle to govern the commons. Science 302: 1907–1912.

16. World Health Organization (2008) The global burden of disease 2004 update. Geneva: World Health Organization.

17. MurrayCJL (1994) Quantifying the burden of disease - the technical basis for disability-adjusted life years. B World Health Organ 72: 429–445.

18. Edejer TTT, Baltussen R, Adam T, Hutubessy R, Acharya A (2003) WHO guide to cost-effectiveness analysis. Geneva: World Health Organization.

19. Sachs JD (2001) Macroeconomics and health: investing in health for economic development. Report of the Commission on Macroeconomics and Health. World Health Organization, Geneva, Switzerland, 2001. Available: http://whqlibdoc.who.int/publications/2001/924154550X.pdf. Accessed 4 November 2011.

20. SIPRI (2011) SIPRI military expenditure database. Stockholm International Peace Research Institute. Accessed 18 January 2013. Available: http://www.sipri.org/.

21. NolteE, McKeeM (2004) Measuring the health of nations: analysis of mortality amenable to health care. J Epidemiol Community H 58: 326–326.

22. OomsG, StucklerD, BasuS, McKeeM (2010) Financing the Millennium Development Goals for health and beyond: sustaining the “Big Push". Global Health 6: 17.

23. PivaP, DoddR (2009) Where did all the aid go? An in-depth analysis of increased health aid flows over the past 10 years. B World Health Organ 87: 930–939.

24. FidlerDP (2007) Reflections on the revolution in health and foreign policy. B World Health Organ 85: 243–244.

25. WHO (2010) CHOosing Interventions that are Cost Effective (WHO-CHOICE). Accessed 18 January 2013. Available: http://www.who.int/choice/costs/prog_costs/en/index.html.

26. LaxminarayanR, MillsAJ, BremanJG, MeashamAR, AlleyneG, et al. (2006) Advancement of global health: key messages from the Disease Control Priorities Project. Lancet 367: 1193–1208.

27. OppenheimerM, PetsonkA (2005) Article 2 of the UNFCCC: historical origins, recent interpretations. Climatic Change 73: 195–226.

28. KlepperG (2011) The future of the European Emission Trading System and the Clean Development Mechanism in a post-Kyoto world. Energ Econ 33: 687–698.

29. Kossoy A, Ambrosi P (2010) State and trends of the carbon market. Washington (D.C.): World Bank.

30. HullB, DeyA, MahajanD, MenziesR, McIntyrePB (2011) Immunisation coverage annual report, 2009. Commun Dis Intell 35: 132–148.

31. ButlerJRG, McIntyreP, Raina MacIntyreC, GilmourR, HowarthAL, et al. (2004) The cost-effectiveness of pneumococcal conjugate vaccination in Australia. Vaccine 22: 1138–1149.

32. CecchiniM, SassiF, LauerJA, LeeYY, Guajardo-BarronV, et al. (2010) Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness. Lancet 376: 1775–1784.

33. AtunR, KnaulFM, AkachiY, FrenkJ (2012) Innovative financing for health: what is truly innovative? Lancet 380: 2044–2049.